| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 216.63B | 202.80B | 156.23B | 138.32B | 164.88B | 163.51B |
| Gross Profit | 186.62B | 170.48B | 143.19B | 127.54B | 150.02B | 148.46B |
| EBITDA | 62.87B | 62.16B | 33.91B | 33.82B | 42.02B | 40.02B |
| Net Income | 45.83B | 39.07B | 23.05B | 21.43B | 20.53B | 21.33B |
Balance Sheet | ||||||
| Total Assets | 16.71T | 16.44T | 16.38T | 16.17T | 17.28T | 16.64T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 3.19T | 4.55T | 4.36T | 5.47T | 5.10T |
| Total Debt | 1.50T | 1.50T | 1.69T | 1.67T | 3.24T | 4.93T |
| Total Liabilities | 16.06T | 15.78T | 15.72T | 15.56T | 16.66T | 16.00T |
| Stockholders Equity | 648.67B | 654.36B | 660.99B | 608.62B | 619.40B | 635.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 235.34B | 0.00 | -1.47T | 452.61B | 2.60T |
| Operating Cash Flow | 0.00 | 241.29B | 0.00 | -1.47T | 462.41B | 2.61T |
| Investing Cash Flow | 0.00 | -1.55T | 131.36B | 367.72B | -82.65B | -231.38B |
| Financing Cash Flow | 0.00 | -48.70B | 344.53B | -10.98B | -14.49B | -12.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥547.49B | 9.62 | ― | 3.15% | 12.71% | 71.94% | |
76 Outperform | ¥865.29B | 9.65 | 8.19% | 3.14% | 15.77% | 27.55% | |
70 Outperform | ¥579.78B | 9.42 | ― | 3.21% | 19.82% | 29.59% | |
69 Neutral | ¥753.74B | 9.74 | ― | 1.41% | 28.83% | 105.24% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥229.72B | 8.99 | ― | 2.38% | 8.43% | 38.21% | |
64 Neutral | ¥1.17T | 11.66 | ― | 2.00% | 18.45% | 41.89% |